Diseases and Conditions Information
Diseases and Conditions Information.
Quick Links:  Asthma & Allergies |  Cancer  |  Depression  |  Anxiety  |  Diabetes  
BROWSE DISEASES AND CONDITIONS DIRECTORY
Medical Resource for all diseases and conditions information - cancer, neurological disorders, birth defects, AIDS, alzheimer's.

ADD and ADHD
Adrenal
AIDS
Allergies
Anxiety
Birth Defects
Blood Disorders
Cancer
Cardiovascular Disorders
Communication Disorders
Depressive Disorders
Diabetes
Digestive Disorders
Dyslexia
Ear, Nose & Throat Disease
Endocrine Disorders
Endometriosis
Eye Disorders
Genetic Disorders
Genitourinary Disorders
Halitosis
Hangover
Hemorrhoids
Hormonal Disorders
Immune Disorders
Infectious Diseases
Insulin Resistance
Miscellaneous
Musculoskeletal Disorders
Neurological Disorders
Nutrition Disorders
Organizations
Parathyroid
Pituitary
Polycystic Ovarian Syndrome
Pregnancy Complications
Premature Ejaculation
Rare Disorders
Registries
Conditions & Diseases Resources
Respiratory Disorders
Sexual Transmitted Diseases
Skin Disorders
Sleep Disorders
Thyroid
Wounds & Injuries

Hansen's Diseases
Outlines the symptoms, testa/diagnosis, causes and risk factors and treatment of this diseases
Agoraphobia
All about Agoraphobia - Anxiety, Dyspnea, Stress, all are symptoms of treatable depression
Down Syndrome
Learn about this genetic disorder, the causes and medical treatment
DISEASES AND CONDITIONS NEWS  
Hormonal contraception tied to increased depression risk
By Andrew M. Seaman (Reuters Health) - Hormonal contraception, including birth control pills or implants, may increase a woman's odds of depression and antidepressant medication use, according to a large study of Danish women. Based on data about prescription drug use for more than 1 million women, researchers found that those who started using hormonal contraception were significantly more likely to subsequently get a first-time prescription for antidepressant medication, compared to women not on hormonal contraception. For adolescent girls, starting on hormonal contraception was tied to an even greater increased risk of antidepressant use.

Amgen, Arrowhead team up on gene-therapies for heart disease
<p><a href="http://news.yahoo.com/amgen-arrowhead-develop-gene-therapies-heart-disease-114729839--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/VWkbjhmaPgnZWhzwLOFIkw--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_us/News/Reuters/2016-09-29T114729Z_1_LYNXNPEC8S0QI_RTROPTP_2_USA-HEALTHCARE-DRUGPRICING.JPG" width="130" height="86" alt="File photo of an Amgen sign at the company&#039;s office in South San Francisco" align="left" title="File photo of an Amgen sign at the company&#039;s office in South San Francisco" border="0" /></a>Amgen Inc said on Thursday it would buy a stake in Arrowhead Pharmaceuticals Inc and collaborate with the company to develop gene-silencing therapies for heart disease. Arrowhead will get $35 million up front and a $21.5 million injection from Amgen that will give the world&#039;s No. 1 biotech company by market value an equity stake of 4.5 percent. Pasadena, California-based Arrowhead will also eligible for up to $617 million in further milestone and equity payments.</p><br clear="all"/>

'Cancer hotels' house China's patient refugees
<p><a href="http://news.yahoo.com/cancer-hotels-house-chinas-patient-refugees-110440410.html"><img src="http://l3.yimg.com/bt/api/res/1.2/H0_q6vs2A1Q60y8saPuNFQ--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_us/News/Reuters/2016-09-29T114412Z_2_LYNXNPEC8S0LW_RTROPTP_2_CHINA-CANCERHOTEL.JPG" width="130" height="86" alt="The Wider Image: China&#039;s cancer patients far from home" align="left" title="The Wider Image: China&#039;s cancer patients far from home" border="0" /></a>By Kim Kyung Hoon BEIJING (Reuters) - In the shadow of one of China&#039;s top cancer hospitals in Beijing, a catacomb-like network of ramshackle brick buildings has become a home-from-home for hundreds of cancer patients and their families waiting for treatment. The cluster of nine buildings, connected by dark, narrow passageways, offers cheap accommodation for patients unable to afford a coveted hospital room, a reflection of the vast inequalities in China&#039;s overburdened healthcare system. Good doctors don&#039;t want to work in small places,&quot; said Liu, 46, a migrant worker who brought his wife more than 750 km (450 miles) to see a specialist in the capital in May. His wife, Wang, 42, was diagnosed with cervical cancer at the beginning of the year, and was told by family she should leave her hometown in Inner Mongolia for treatment.</p><br clear="all"/>

FDA approves Medtronic's 'artificial pancreas' for diabetes
Medtronic Plc won U.S. approval on Wednesday for an "artificial pancreas" that is the first device to automatically deliver the right dose of insulin to patients with type 1 diabetes, freeing them from continually monitoring insulin levels throughout each day. The U.S. Food and Drug Administration, in its approval of the device, the MiniMed 670G, hailed it as a breakthrough. The device offers type 1 diabetics "greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin," Dr. Jeffrey Shuren, director of the FDA's medical device division, said in a statement.

FDA approves 'artificial pancreas' to manage diabetes
<p><a href="http://news.yahoo.com/fda-approves-device-automatically-manage-191338168.html"><img src="http://l2.yimg.com/bt/api/res/1.2/ps9WZwcLogBpABDKZ_AXZw--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cHhvZmY9NTA7cHlvZmY9MDtxPTc1O3c9MTMw/http://media.zenfs.com/en_us/News/ap_webfeeds/6a1e90187686433badc1cff63dd47d95.jpg" width="130" height="86" alt="This image provided by Medtronic shows its MiniMed 670G system. Federal regulators have approved a first-of-a-kind &quot;artificial pancreas,&quot; a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed. The device from Medtronic was approved Wednesday, Sept. 28, 2016, for patients with Type 1 diabetes, the kind usually diagnosed during childhood. (Medtronic via AP)" align="left" title="This image provided by Medtronic shows its MiniMed 670G system. Federal regulators have approved a first-of-a-kind &quot;artificial pancreas,&quot; a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed. The device from Medtronic was approved Wednesday, Sept. 28, 2016, for patients with Type 1 diabetes, the kind usually diagnosed during childhood. (Medtronic via AP)" border="0" /></a>WASHINGTON (AP) — Federal regulators have approved a first-of-a-kind &quot;artificial pancreas,&quot; a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed.</p><br clear="all"/>

Exercise found to reduce fatigue and improve physical fitness in women undergoing breast cancer treatments
<p><a href="http://news.yahoo.com/exercise-found-reduce-fatigue-improve-physical-fitness-women-170213939.html"><img src="http://l1.yimg.com/bt/api/res/1.2/XUO5kS9rVzOoFcMCOrfFUA--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_US/News/US-AFPRelax/istock_00006288.46a9d114511.original.jpg" width="130" height="86" alt="Exercise also appeared to slightly improve cognitive function." align="left" title="Exercise also appeared to slightly improve cognitive function." border="0" /></a>Breast Cancer Awareness Month kicks off in October to raise awareness about the disease, its signs, symptoms, screening and diagnosis. Ahead of this, an extensive British review -- based on 32 clinical trials covering 2,626 women -- has highlighted the advantages of exercise for women in all stages of the disease. The review collates various studies focusing on women undergoing very different kinds of therapy and surgery for breast cancer.</p><br clear="all"/>

Cancer patients may be overly optimistic about early drug trial participation
By Andrew M. Seaman (Reuters Health) - People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to test the drug's safety. Just 4 percent to 20 percent of participants may see their cancer respond to the drug, the authors write in the journal Cancer.

Kite immunotherapy drug helps blood cancer patients in study
(Reuters) - Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial. Shares of Kite, which had been halted before the release of the news, rose 11 percent when trading resumed. Some 76 percent of patients taking the drug, called KTE-C19, showed significant tumor shrinkage, including 47 percent who had no remaining signs of cancer at least three months after receiving the treatment, Kite said.


Health Directory | About Us | Submit Your Site | How to link to us | Contact Us
DiseasesConditions lists all the major web sites and companies for practically every country in the world. Browse our massive index of thousands of dedicated diseases and conditions web sites. All logos, trademarks and other propriety marks belong to their respective owners and do not reflect an association or recommendation by any of the parties.
©2005 DiseasesConditions.com - All Rights Reserved.